Lento Bio develops small molecule therapeutics that repair molecular damage in the aging eye — beginning with the lens, where vision loss starts.
The lens stiffens and degrades universally with age. For most, this is the first major, symptomatic aging disorder they experience.
Our therapies target the root biology of this process, restoring natural physiology rather than masking symptoms.
Eyedrops that reverse age-induced vision loss — not mask it.
1.8 billion people worldwide have presbyopia — the universal, age-related loss of near vision. Everyone over 45 knows the feeling: arms stretched out, squinting at a menu, reaching for readers. It’s the one condition that spares no one. Today’s only option — corrective lenses — doesn’t treat the underlying cause, and limits everyday activities from reading your phone to working on a computer.
LB-01 is a topical eye drop designed to reverse the molecular damage that stiffens the crystalline lens. Not a symptom mask — a repair mechanism inspired by the body’s own protective chemistry.
